Vaccine Therapy in Treating Patients With Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: BIOLOGICAL: recombinant vaccinia-MUC1 vaccine|BIOLOGICAL: recombinant vaccinia-TRICOM vaccine|OTHER: laboratory biomarker analysis|PROCEDURE: quality-of-life assessment
Sponsor: National Cancer Institute (NCI)